ATE197047T1 - 1,4-di(phenylalkyl)piperazinderivate - Google Patents

1,4-di(phenylalkyl)piperazinderivate

Info

Publication number
ATE197047T1
ATE197047T1 AT94921809T AT94921809T ATE197047T1 AT E197047 T1 ATE197047 T1 AT E197047T1 AT 94921809 T AT94921809 T AT 94921809T AT 94921809 T AT94921809 T AT 94921809T AT E197047 T1 ATE197047 T1 AT E197047T1
Authority
AT
Austria
Prior art keywords
phenylalkyl
different
same
represents lower
piperazine derivatives
Prior art date
Application number
AT94921809T
Other languages
English (en)
Inventor
Yoichi Kawashima
Junzo Matsumoto
Kiyoshi Matsuno
Toshihiko Senda
Heiko Hirano
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE197047T1 publication Critical patent/ATE197047T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
AT94921809T 1993-07-28 1994-07-25 1,4-di(phenylalkyl)piperazinderivate ATE197047T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP18583993 1993-07-28
PCT/JP1994/001220 WO1995004050A1 (fr) 1993-07-28 1994-07-25 Nouveau derive de 1,4-di(phenylalkyl)piperazine

Publications (1)

Publication Number Publication Date
ATE197047T1 true ATE197047T1 (de) 2000-11-15

Family

ID=16177784

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94921809T ATE197047T1 (de) 1993-07-28 1994-07-25 1,4-di(phenylalkyl)piperazinderivate

Country Status (11)

Country Link
US (1) US5736546A (de)
EP (1) EP0711763B1 (de)
KR (1) KR100299734B1 (de)
CN (1) CN1042029C (de)
AT (1) ATE197047T1 (de)
CA (1) CA2168264A1 (de)
DE (1) DE69426157T2 (de)
ES (1) ES2151930T3 (de)
FI (1) FI960364A (de)
NO (1) NO960270D0 (de)
WO (1) WO1995004050A1 (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5859295A (en) * 1994-12-05 1999-01-12 University Of Kentucky Research Foundation Canavanine analogs and their use as chemotherapeutic agents
US5889006A (en) * 1995-02-23 1999-03-30 Schering Corporation Muscarinic antagonists
IL117149A0 (en) * 1995-02-23 1996-06-18 Schering Corp Muscarinic antagonists
HUP9601331A3 (en) * 1996-05-17 2000-06-28 Egyt Gyogyszervegyeszeti Gyar Piperazine- and homopiperazine-derivatives, process for producing them and pharmaceutical compositions containing them
US5952349A (en) * 1996-07-10 1999-09-14 Schering Corporation Muscarinic antagonists for treating memory loss
ATE227708T1 (de) * 1996-07-10 2002-11-15 Schering Corp 1,4-disubstituierte piperdine als muskarin- antagonisten
US5860391A (en) * 1996-08-06 1999-01-19 First Brands Corporation Absorbents containing activated carbons
US6713651B1 (en) * 1999-06-07 2004-03-30 Theravance, Inc. β2-adrenergic receptor agonists
DE69934902T2 (de) * 1998-11-09 2007-10-18 Santen Pharmaceutical Co., Ltd Medikament gegen drogenabhängigkeit
WO2001000604A1 (en) * 1999-06-30 2001-01-04 Santen Pharmaceutical Co., Ltd. Brain sigma-1 receptor-binding ligand
DE10050236A1 (de) * 2000-10-11 2002-04-25 Merck Patent Gmbh Verwendung bestimmter Substanzen, die an den Sigma-Rezeptor binden, zur Behandlung von Sarkomen und Karzinomen
CN1181065C (zh) 2002-05-08 2004-12-22 上海医药工业研究院 芳烷甲酰烷基哌嗪衍生物及其作为脑神经保护剂的应用
CN1172919C (zh) * 2002-06-03 2004-10-27 上海医药工业研究院 芳烷醇哌嗪衍生物及其在制备抗抑郁症药物中的应用
WO2004110387A2 (en) * 2003-06-12 2004-12-23 Agy Therapeutics, Inc. Sigma ligands for neuronal regeneration and functional recovery
WO2005028457A1 (en) * 2003-09-23 2005-03-31 Fermion Oy Preparation of quetiapine
DE102004061593A1 (de) 2004-12-21 2006-06-22 Abbott Gmbh & Co. Kg Substituierte N-heterocyclische Verbindungen und ihre therapeutische Verwendung
WO2007021545A2 (en) * 2005-08-09 2007-02-22 M's Science Corporation Piperazine derivatives
JP2009528976A (ja) * 2005-09-23 2009-08-13 株式会社エムズサイエンス ピペリジン誘導体及びピペラジン誘導体
EP1940389A2 (de) 2005-10-21 2008-07-09 Braincells, Inc. Modulation von neurogenese durch pde-hemmung
EP2314289A1 (de) 2005-10-31 2011-04-27 Braincells, Inc. Gaba-rezeptor-vermittelte modulation von neurogenese
PL1976525T3 (pl) 2006-01-27 2011-05-31 Ms Science Corp Pochodne piperydyny oraz piperazyny
CA2642630A1 (en) * 2006-02-15 2007-08-30 M's Science Corporation Piperazine derivatives
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP2026813A2 (de) 2006-05-09 2009-02-25 Braincells, Inc. 5-ht-rezeptor-vermittelte neurogenese
EP2377531A2 (de) 2006-05-09 2011-10-19 Braincells, Inc. Neurogenese mittels Angiotensin-Modulation
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2008060271A1 (en) * 2006-11-13 2008-05-22 M's Science Corporation Sigma ligands for neuronal regeneration and functional recovery
US8461389B2 (en) 2008-04-18 2013-06-11 University College Dublin, National University Of Ireland, Dublin Psycho-pharmaceuticals
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
US8673920B2 (en) * 2009-05-06 2014-03-18 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
US9073882B2 (en) 2010-10-27 2015-07-07 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
US9056859B2 (en) 2010-10-29 2015-06-16 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
AU2012299227A1 (en) 2011-08-19 2014-02-20 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
EP2755656B1 (de) 2011-09-16 2016-09-07 Merck Sharp & Dohme Corp. Inhibitoren des renalen kaliumkanals der äusseren medulla
US8999990B2 (en) 2011-10-25 2015-04-07 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
EP2771004B1 (de) 2011-10-25 2016-05-18 Merck Sharp & Dohme Corp. Inhibitoren des renalen kaliumkanals der äusseren medulla
US9139585B2 (en) 2011-10-31 2015-09-22 Merck Sharp & Dohme Corp. Inhibitors of the Renal Outer Medullary Potassium channel
US9493474B2 (en) 2011-10-31 2016-11-15 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
US9108947B2 (en) 2011-10-31 2015-08-18 Merck Sharp & Dohme Corp. Inhibitors of the Renal Outer Medullary Potassium channel
US9206199B2 (en) 2011-12-16 2015-12-08 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
AR092031A1 (es) 2012-07-26 2015-03-18 Merck Sharp & Dohme Inhibidores del canal de potasio medular externo renal
WO2014085210A1 (en) 2012-11-29 2014-06-05 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
EP2934533B1 (de) 2012-12-19 2017-11-15 Merck Sharp & Dohme Corp. Inhibitoren des kaliumkanals des äusseren nierenmarks
WO2014126944A2 (en) 2013-02-18 2014-08-21 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
EP2968288B1 (de) 2013-03-15 2018-07-04 Merck Sharp & Dohme Corp. Inhibitoren des renalen kaliumkanals der äusseren medulla
US9751881B2 (en) 2013-07-31 2017-09-05 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
WO2015065866A1 (en) 2013-10-31 2015-05-07 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
WO2016127358A1 (en) 2015-02-12 2016-08-18 Merck Sharp & Dohme Corp. Inhibitors of renal outer medullary potassium channel

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5583771A (en) * 1978-12-20 1980-06-24 Kanebo Ltd N-substituted trimethoxybenzylpiperazine derivative and its acid addition salt
JPS60155171A (ja) * 1983-12-10 1985-08-15 Wako Pure Chem Ind Ltd ポリメトキシベンジルピペラジン誘導体
JPS6133827A (ja) * 1984-07-27 1986-02-17 Mitsubishi Electric Corp 放電加工装置
JP2722250B2 (ja) * 1989-05-30 1998-03-04 興和株式会社 新規なジアミン化合物及びこれを含有する脳機能障害改善剤
JPH05503517A (ja) * 1989-12-18 1993-06-10 バージニア・コモンウェルス・ユニバーシティ シグマレセプターリガンド及びその用途
EP0566189A1 (de) * 1992-04-13 1993-10-20 Akzo N.V. Psychotroop-Piperazinderivat
US5428037A (en) * 1993-04-09 1995-06-27 Syntex Pharmaceuticals, Ltd. Heterocyclic derivatives in the treatment of Ischaemia and related diseases

Also Published As

Publication number Publication date
NO960270L (no) 1996-01-23
DE69426157T2 (de) 2001-05-17
NO960270D0 (no) 1996-01-23
WO1995004050A1 (fr) 1995-02-09
CN1042029C (zh) 1999-02-10
FI960364A0 (fi) 1996-01-26
ES2151930T3 (es) 2001-01-16
CN1128026A (zh) 1996-07-31
KR100299734B1 (ko) 2002-01-09
CA2168264A1 (en) 1995-02-09
FI960364A (fi) 1996-01-26
EP0711763A1 (de) 1996-05-15
EP0711763B1 (de) 2000-10-18
US5736546A (en) 1998-04-07
EP0711763A4 (de) 1996-06-12
DE69426157D1 (de) 2000-11-23

Similar Documents

Publication Publication Date Title
ATE197047T1 (de) 1,4-di(phenylalkyl)piperazinderivate
PT778277E (pt) Derivados heterociclicos substituidos como antagonistas do crf
DE69028136D1 (de) Alkoxyiminoacetamid-Derivate und ihre Verwendung als pilztötendes Mittel
ATE119774T1 (de) Imidazopyridinderivate und ihre verwendung.
ATE240734T1 (de) Zubereitung von xanthinderivaten als feste dispersion
EP0563345A4 (en) Novel 4-arylpiperazines and 4-arylpiperidines
NO881253D0 (no) 1,4-disubstituerte piperazinforbindelser og fremgangsmaate for deres fremstilling.
ATE125532T1 (de) Nitromethylenverbindungen, deren herstellung und deren verwendung als pestizide.
DE69717970T2 (de) Chinolin carbonsaure-derivate und ihre salze
AU9281198A (en) Benzofuran derivatives
DK240084D0 (da) New beta-carboline-3-oxadiazolyl derivatives
UY24010A1 (es) Nuevos pirrolocarbazoles
ATE89003T1 (de) Dioxaphosphorin-verbindungen und damit stabilisierte polyolefin-zusammensetzungen.
DE69906243T2 (de) 2-Indanmethanolderivate und ihre Verwendung als Riechstoffe
MX9703363A (es) Nuevos derivados de pirimidiniloxi- y pirimidinilamino etilfenil-dioxolano.
ATE61580T1 (de) 3-propenylpyridine und ihre verwendung als fungizide.
DE68916126D1 (de) Optisch aktive Piperazin-Derivate.
ATE148449T1 (de) Neue verwendung von (s) amino-2-dichloro-3,4- benzyl)-2-propanol-1 enantiomere derivate

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner